Curative treatment for oligometastatic gastroesophageal cancer– results of a prospective multicenter study
This study found curative treatment to be a relatively safe option, with an overall survival of 20.8 months and no postoperative mortality.
Authors
- Michael Hermansson
- Éva Szabó (ORCID: https://orcid.org/0000-0001-8306-6977)
- David Edholm (ORCID: https://orcid.org/0000-0003-2172-5310)
- Berit Sunde (ORCID: https://orcid.org/0000-0003-3506-9166)
- Jakob Hedberg (ORCID: https://orcid.org/0000-0003-1308-4592)
- Fredrik Klevebro (ORCID: https://orcid.org/0000-0002-1695-4103)
- Ioannis Rouvelas (ORCID: https://orcid.org/0000-0003-0774-1904)
- Maria Nilsson (ORCID: https://orcid.org/0000-0001-8416-4819)
- Ulrika Smedh (ORCID: https://orcid.org/0000-0003-0888-0586)
- Mats Lindblad (ORCID: https://orcid.org/0000-0003-3575-6986)
- Nora Norén
- Lars Lundell
Institutions
- Linköping University (SE)
- Karolinska University Hospital (SE)
- Uppsala University Hospital (SE)
- Lund University (SE)
- Sahlgrenska University Hospital (SE)
- Odense University Hospital (DK)
- Karolinska Institutet (SE)
- Örebro University Hospital (SE)
- Skåne University Hospital (SE)
Publication Details
- Journal
- Langenbeck s Archives of Surgery
- Published
- 2024-12-16
- DOI
- https://doi.org/10.1007/s00423-024-03575-7
- Citations
- 1
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- Karolinska Institutet